Cambridge Investment Research Advisors
VXRT

Cambridge Investment Research Advisors’s Vaxart VXRT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,832
Closed -$24K – 3218
2022
Q3 		$24K Buy
+10,832
New +$37.4K ﹤0.01% 2993
2022
Q2 		– Sell
-26,640
Closed -$134K – 3223
2022
Q1 		$134K Buy
26,640
+322
+1% +$1.63K ﹤0.01% 2966
2021
Q4 		$165K Buy
+26,318
New +$180K ﹤0.01% 2943
2021
Q2 		– Sell
-32,951
Closed -$199K – 3175
2021
Q1 		$199K Buy
32,951
+22,185
+206% +$171K ﹤0.01% 2632
2020
Q4 		$61K Sell
10,766
-9,490
-47% -$60.4K ﹤0.01% 2640
2020
Q3 		$135K Sell
20,256
-8,468
-29% -$75.4K ﹤0.01% 2337
2020
Q2 		$254K Buy
+28,724
New +$82.5K ﹤0.01% 2020

Other funds holding VXRT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors's VXRT Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 10,832 shares — an estimated $24K sold.

Cambridge Investment Research Advisors first reported a position in VXRT in Q2 2020 and held it in 7 quarters. The position peaked at $254K in Q2 2020. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,832 Vaxart shares in Q4 2022, an estimated $24K.
  • Cambridge Investment Research Advisors first reported a position in Vaxart in Q2 2020 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Vaxart position peaked at $254K in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.